Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents

BACKGROUND: Virotherapy represents a promising approach for ovarian cancer. In this regard, conditionally replicative adenovirus (CRAd) has been translated to the context of human clinical trials. Advanced design of CRAds has sought to exploit their capacity to induce anti-tumor immunization by conf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Ovarian Res
Autores principales: González-Pastor, Rebeca, Ashshi, Ahmad Mohammad, El-Shemi, Adel Galal, Dmitriev, Igor P., Kashentseva, Elena A., Lu, Zhi Hong, Goedegebuure, S. Peter, Podhajcer, Osvaldo L., Curiel, David T.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Brief Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376676/
https://ncbi.nlm.nih.gov/pubmed/30767772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-019-0493-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares